Scientific engineering made to measure to accelerate your R&D and diagnostics pipeline.
We are the scientific base for pharma, biotech, CROs and reagent makers that demand complex analytical assays, regulatory validation and cell-line authentication at international standards.
Your arm for advanced research
and scientific engineering.
Base Científica operates as the advanced scientific engineering arm of your projects: we design, optimize and execute complex assays under strict NDA, in our own labs compliant with ANVISA/FDA/ICH.
We serve pharma, next-generation biotech, CROs that need scientific depth, and demanding reagent makers — in Brazil and abroad.
Five fronts. One scientific engineering team.
Each front addresses a specific pipeline pain — from first pre-clinical assay to regulatory validation and biological raw-material authentication.
Pre-Clinical Research
A reference in innovation for pre-clinical assays — everything your study needs in one place.
Validation of Diagnostic & Pharmaceutical Products
Development and validation of diagnostic and pharmaceutical products with absolute regulatory compliance.
Cell Line Authentication
Precision and reliability for safe pre-clinical results — 16+ STR markers analyzed in 10 days.
Base for CROs
Add high-level R&D engineering and ANVISA/FDA infrastructure to your CRO's portfolio — with no fixed costs.
Women's Health
Molecular biology reference lab — HPV, STIs, gynecological health, fetal sexing and genetics, with nationwide logistics.
Cultivating long-term relationships and continuous collaboration.
We collaborate with leading companies and institutions in molecular diagnostics, biotechnology, healthcare and academic research.
What we're thinking about.
Why cell line authentication is the silent foundation of your pipeline
Studies in high-impact journals continue to be retracted due to misidentified cell lines. Understand how the ANSI/ATCC ASN-0002 standard protects your reputation.
Analytical validation ICH Q2(R2): what changes for biologics and diagnostics
The ICH Q2 revision expands validation criteria for multivariate analytical methods and biotech products. We translate what that means at the bench.
3D cellular models for mRNA and advanced therapies
Organoids and spheroids are no longer academic experiments. For complex therapeutic modalities they are the only practical way to generate predictive data.
Let's design the scope of your next study.
Send a briefing or request a meeting with our specialists — we reply within 24 business hours.